News

Sarepta halts Elevidys shipments following FDA pressure
Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.
Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug ...
Daily Excelsior16m
World markets mixed, Japan’s shares dip after election leaves Ishiba’s future in doubt
World shares were mixed on Tuesday after US stock indexes inched to more records at the start of a week of profit updates ...
Asian markets are mixed and Japan's shares slip after election leaves Ishiba's future in doubt
Asian markets are mixed after U.S. stock indexes hit new records on Monday. Oil prices fell and U.S. futures were little ...
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. AstraZeneca has become the latest pharma firm to announce a ...